Revenue
-
Net Income
-$74.2M
▼ 27.9% YoY
EPS
$-4.05
▲ 40.7% YoY
Cash
$253.8M
▲ 79.7% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Ruddy Marcella K. Chief Medical Officer | Sell | Mar 6, 2026 | 10.0K | $30.00 | $300K | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Vest | Mar 6, 2026 | 2.5K | $2.38 | $6K | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Vest | Mar 6, 2026 | 215 | $14.71 | $3K | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Sell | Mar 6, 2026 | 6.0K | $30.00 | $181K | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Sell | Mar 6, 2026 | 215 | $35.00 | $8K | Form 4 ↗ |
REICIN ALISE Chief Executive Officer | Grant | Mar 4, 2026 | 76.5K | $0.00 | $0 | Form 4 ↗ |
Schwabish Marc Chief Business Officer | Grant | Mar 4, 2026 | 19.5K | $0.00 | $0 | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Grant | Mar 4, 2026 | 23.0K | $0.00 | $0 | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Sell | Mar 4, 2026 | 1.6K | $25.00 | $41K | Form 4 ↗ |
Lochner Daniel Chief Financial Officer | Grant | Mar 4, 2026 | 26.5K | $0.00 | $0 | Form 4 ↗ |
Ruddy Marcella K. Chief Medical Officer | Grant | Mar 4, 2026 | 26.5K | $0.00 | $0 | Form 4 ↗ |
McNamara Peter Chief Scientific Officer | Sell | Mar 3, 2026 | 1.6K | $22.06 | $36K | Form 4 ↗ |
REICIN ALISE Chief Executive Officer | Buy | Feb 11, 2026 | 2.5K | $21.10 | $53K | Form 4 ↗ |
Schwabish Marc Chief Business Officer | Vest | Feb 10, 2026 | 4.5K | $2.38 | $11K | Form 4 ↗ |
Lochner Daniel Chief Financial Officer | Buy | Feb 10, 2026 | 6.0K | $21.61 | $130K | Form 4 ↗ |
Schwabish Marc Chief Business Officer | Sell tax | Feb 4, 2026 | 1.6K | $23.22 | $38K | Form 4 ↗ |
Ruddy Marcella K. Chief Medical Officer | Sell tax | Feb 4, 2026 | 2.1K | $23.22 | $48K | Form 4 ↗ |